| Dr Maureen Erin Stephenson, DO | |
|
550 N 5th St, Suite 110, Rapid City, SD 57701-1375 | |
| (605) 737-7777 | |
| Not Available |
| Full Name | Dr Maureen Erin Stephenson |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 550 N 5th St, Rapid City, South Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265546329 | NPI | - | NPPES |
| 7100432 | Medicaid | SD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 4785 (South Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Maureen Erin Stephenson, DO Po Box 2652, Rapid City, SD 57709-2652 Ph: (605) 737-7777 | Dr Maureen Erin Stephenson, DO 550 N 5th St, Suite 110, Rapid City, SD 57701-1375 Ph: (605) 737-7777 |
News Archive
More than seventy percent of people who contract Hepatitis C will live with the virus that causes it for the rest of their lives and some will develop serious liver disease including cancer. However, 30 to 40 percent of those infected somehow defeat the infection and get rid of the virus with no treatment. In this week's Advanced Online Publication at Nature, Johns Hopkins researchers working as part of an international team report the discovery of the strongest genetic alteration associated with the ability to get rid of the infection.
Med Biogene Inc., a Vancouver-based life sciences company, has been charged with fraud, and Pittsburgh-based Precision Therapeutics, Inc., was charged with tortious interference in an amended complaint filed today by Signal Genetics in Supreme Court for the County of New York.
Scientists at The University of Texas M. D. Anderson Cancer Center have identified a protein that serves as a master regulator of skin cancer - a finding that could lead to new ways to prevent skin cancer before it starts.
Merrimack Pharmaceuticals, Inc. announced today that five patients have received therapy in a Phase I clinical study combining MM-111 with multiple standard treatment regimens for patients with advanced HER2 positive (HER2+) solid tumors.
› Verified 6 days ago
Steven K Hata, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2929 5th Street, 240, Rapid City, SD 57701 Phone: 605-341-3770 Fax: 605-341-8692 | |
Dr. Douglas Thorburn Brown, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2929 5th Street, 240, Rapid City, SD 57701 Phone: 605-341-3770 Fax: 605-341-8692 | |
Kirsten A Butz, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 915 Mt View Rd, Rapid City, SD 57702 Phone: 605-755-7300 Fax: 605-755-0707 | |
Dr. Terry R Hicks, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 350 Elk St, Rapid City, SD 57701 Phone: 605-343-7262 Fax: 605-343-7293 | |
Dr. Ryan Gianatasio, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 677 Cathedral Dr, Rapid City, SD 57701 Phone: 605-755-4150 | |
Dr. Mark Thomas Garry, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 10 Van Buren St, Rapid City, SD 57701 Phone: 605-721-8939 | |
Heather G Cwach, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2929 5th Street, 240, Rapid City, SD 57701 Phone: 605-341-3770 Fax: 605-341-8692 |